{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T23:41:08Z","timestamp":1690933268522},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1097\/prs.0000000000007316","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:02:16Z","timestamp":1603411336000},"page":"1080-1081","source":"Crossref","is-referenced-by-count":0,"title":["Discussion: Collagenase Treatment of Dupuytren\u2019s Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction"],"prefix":"10.1097","volume":"146","author":[{"given":"Kyle J.","family":"Chepla","sequence":"first","affiliation":[{"name":"From MetroHealth Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230801","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/PRS.0000000000007243","article-title":"Collagenase treatment of Dupuytren disease with minimum 5-year follow-up: Recurrence, reintervention, and satisfaction.","volume":"146","author":"Zhang","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R2-20230801","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R3-20230801","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/1753193418790157","article-title":"Five-year results after collagenase treatment of Dupuytren disease.","volume":"43","author":"Werlinrud","year":"2018","journal-title":"J Hand Surg Eur Vol"},{"key":"R4-20230801","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2106\/JBJS.17.01128","article-title":"Percutaneous needle fasciotomy versus collagenase treatment for Dupuytren contracture: A randomized controlled trial with a two-year follow-up.","volume":"100","author":"Str\u00f6mberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R5-20230801","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: A randomized controlled trial.","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"key":"R6-20230801","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhsa.2019.07.017","article-title":"Outcomes and direct costs of needle aponeurotomy, collagenase injection, and fasciectomy in the treatment of Dupuytren contracture.","volume":"44","author":"Leafblad","year":"2019","journal-title":"J Hand Surg Am"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T23:10:53Z","timestamp":1690931453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000007316","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}